3.1(top 10%)
impact factor
27.2K(top 1%)
papers
423.8K(top 1%)
citations
169(top 2%)
h-index
3.3(top 10%)
extended IF
33.9K
all documents
496.4K
doc citations
240(top 2%)
g-index

Top Articles

#TitleJournalYearCitations
1Targeting PI3K/Akt/mTOR Signaling in CancerFrontiers in Oncology20141,306
2Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and LimitationsFrontiers in Oncology20181,191
3Role of Matrix Metalloproteinases in Angiogenesis and CancerFrontiers in Oncology2019858
4Lactate in the Regulation of Tumor Microenvironment and Therapeutic ApproachesFrontiers in Oncology2019776
5Targeting PI3K/mTOR Signaling in CancerFrontiers in Oncology2014747
6The role of BCL-2 family proteins in regulating apoptosis and cancer therapyFrontiers in Oncology2022707
7Implications of the Hybrid Epithelial/Mesenchymal Phenotype in MetastasisFrontiers in Oncology2015653
8Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACiFrontiers in Oncology2018602
9Radiation-induced brain injury: A reviewFrontiers in Oncology2012580
10Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and TherapyFrontiers in Oncology2019561
11Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical PracticeFrontiers in Oncology2020543
12Tumor-Associated Macrophages: Recent Insights and TherapiesFrontiers in Oncology2020542
13Trastuzumab: Updated Mechanisms of Action and Resistance in Breast CancerFrontiers in Oncology2012510
14The KEAP1–NRF2 System in CancerFrontiers in Oncology2017488
15Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in HepatocarcinomaFrontiers in Oncology2019470
16Targeting Macrophages in Cancer: From Bench to BedsideFrontiers in Oncology2018455
17CRISPR Gene Therapy: Applications, Limitations, and Implications for the FutureFrontiers in Oncology2020452
18PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?Frontiers in Oncology2022449
19Mitochondrial Dysfunction in CancerFrontiers in Oncology2013435
20DNA Methyltransferases: A Novel Target for Prevention and TherapyFrontiers in Oncology2014435
21Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO ClassificationFrontiers in Oncology2017426
22Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic ApproachesFrontiers in Oncology2022425
23Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting TumorigenesisFrontiers in Oncology2020424
24Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?Frontiers in Oncology2020408
25Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational ResearchFrontiers in Oncology2013405
26Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic ApplicationsFrontiers in Oncology2018405
27PTEN: Multiple Functions in Human Malignant TumorsFrontiers in Oncology2015401
28The Global Landscape of EBV-Associated TumorsFrontiers in Oncology2019394
29Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor MicroenvironmentFrontiers in Oncology2014390
30Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck CancerFrontiers in Oncology2015380
31The Multidisciplinary Team (MDT) Approach and Quality of CareFrontiers in Oncology2020372
32Microtubules and Their Role in Cellular Stress in CancerFrontiers in Oncology2014371
33Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in CancerFrontiers in Oncology2018363
34“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling PathwayFrontiers in Oncology2018356
35Altered Tumor-Cell Glycosylation Promotes MetastasisFrontiers in Oncology2014354
36Radiation-Induced Oral MucositisFrontiers in Oncology2017350
37Recent Advances in the Treatment of Breast CancerFrontiers in Oncology2018348
38The Keap1–Nrf2 system in cancers: stress response and anabolic metabolismFrontiers in Oncology2012347
39Exploratory Study to Identify Radiomics Classifiers for Lung Cancer HistologyFrontiers in Oncology2016344
40Fluorescence-Guided SurgeryFrontiers in Oncology2017344
41Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and MetastasisFrontiers in Oncology2018342
42The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell PlasticityFrontiers in Oncology2018339
43Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate CancersFrontiers in Oncology2020338
44Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell FateFrontiers in Oncology2017337
45The role of IL-6/JAK2/STAT3 signaling pathway in cancersFrontiers in Oncology2022332
46Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody TherapyFrontiers in Oncology2018331
47Resistance Mechanisms to Anti-angiogenic Therapies in CancerFrontiers in Oncology2020325
48Radiation-Induced Lung Injury (RILI)Frontiers in Oncology2019314
49Chronic Stress Promotes Cancer DevelopmentFrontiers in Oncology2020313
50Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and HepatocarcinogenesisFrontiers in Oncology2018307